Context Therapeutics Inc. Common Stock (CNTX) is a publicly traded Healthcare sector company. As of September 9, 2026, CNTX trades at $0.37 with a market cap of $33.23M and a P/E ratio of -0.98. CNTX moved -0.88% today. Year to date, CNTX is -74.40%; over the trailing twelve months it is -54.19%. Its 52-week range spans $0.35 to $3.62. Analyst consensus is strong buy with an average price target of $3.20. Rallies surfaces CNTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks CNTX insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $0.37 |
| Market Cap | $33.23M |
| P/E Ratio | -0.98 |
| EPS | $-0.38 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.62 |
| 52-Week Low | $0.35 |
| Volume | 21.30K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-36.12M |
| Gross Margin | 0.00% |
6 analysts cover CNTX: 0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $3.20.